5-amino-6,7,8-trifluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 127199-34-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 5-amino-6,7,8-trifluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• 英文别名: 5-amino-6,7,8-trifluoro-1-[2-(S)-fluoro-1-(R)-cyclopropyl]-1,4-dihydro-4-oxoquinoline-3-carboxylic acid；5-amino-6,7,8-trifluoro-1-[(1R,2S)-2-fluorocyclopropyl]1,4-dihydro-4-oxoquinoline-3-carboxylic acid；5-amino-6,7,8-trifluoro-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-4-oxoquinoline-3-carboxylic acid；5-amino-6,7,8-trifluoro-1-[(1R,2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid
• CAS: 127199-34-2
• 化学式: C₁₃H₈F₄N₂O₃
• 分子量: 316.212
• InChiKey: JSCZIAPHPBQUJU-CRCLSJGQSA-N

物化性质

• 沸点：
  521.5±50.0 °C(Predicted)
• 密度：
  1.74±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  83.6
• 氢给体数：
  2
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  5-amino-6,7,8-trifluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 在 盐酸 、 三乙胺 作用下， 以 乙腈 为溶剂， 生成 5-Amino-7-(6-amino-octahydro-4-aza-cyclopropa[f]inden-4-yl)-6,8-difluoro-1-((1R,2S)-2-fluoro-cyclopropyl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
  参考文献：
  名称：

  Synthesis and antibacterial activity of novel 6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxoquinoline-3-carboxylic acids bearing cyclopropane-fused 2-amino-8-azabicyclo[4.3.0]nonan-8-yl substituents at the C-7 position

  摘要：

  A series of novel 6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxoquinoline-3-carboxylic acids bearing cyclopropane-fused 2-amino-8-azabicyclo[4.3.0]nonan-8-yl substituents at the C-7 position were synthesized to obtain potent drugs for the treatment of Gram-positive infections. Some compounds exhibited excellent antibacterial activity, and potent inhibitory activity against bacterial DNA topoisomerase IV. In addition, some of the potent compounds showed reduced inhibitory activity against human DNA topoisomerase II compared with the corresponding noncyclopropane-fused compounds. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.07.064

文献信息

• Pyridonecarboxylic acid derivatives substituted by a bicyclic amino
  申请人：Daiichi Pharmaceutical Co., Ltd.

  公开号：US05849757A1

  公开（公告）日：1998-12-15

  This invention relates to a N.sub.1 -(halogenocyclopropyl)-substituted pyridonecarboxylic acid derivative represented by the following formula (I): ##STR1## wherein X.sup.1 is a halogen atom or a hydrogen atom; X.sup.2 is a halogen atom; R.sup.1 is a hydrogen atom, a hydroxyl group, a thiol group, a halogenomethyl group, an amino group, an alkyl group or an alkoxy group which may have a substituent group; R.sup.2 is a group represented by the following formula (II): ##STR2## wherein R.sup.3 and R.sup.4 are independently a hydrogen atom or an alkyl group and n is an integer of 1 or 2; A is a nitrogen atom or a partial structure of the following formula (III): ##STR3## wherein X.sup.3 is a hydrogen atom, a halogen atom, a cyano group, an amino group, an alkyl group, a halogenomethyl group, an alkoxyl group or a halogenomethoxyl group which may have a substituent group; and R is a hydrogen atom, a phenyl group, an acetoxymethyl group, a pivaloyloxymethyl group, an ethoxycarbonyl group, a choline group, a dimethylaminoethyl group, a 5-indanyl group, a phthalidynyl group, a 5-alkyl-2-oxo-1,3-dioxol-4-ylmethyl group, a 3-acetoxy-2-oxobutyl group, an alkyl group, an alkoxymethyl group or a phenylalkyl group, and provides a heterocyclic compound useful as antibacterial drugs.

  这项发明涉及一种由以下式（I）表示的N.sub.1-(卤代环丙基)-取代吡啶酮羧酸衍生物：其中X.sup.1是卤素原子或氢原子；X.sup.2是卤素原子；R.sup.1是氢原子、羟基、硫醇基、卤代甲基基团、氨基、烷基或可能具有取代基团的烷氧基；R.sup.2是由以下式（II）表示的基团：其中R.sup.3和R.sup.4独立地是氢原子或烷基，n是1或2的整数；A是氮原子或以下式（III）的部分结构：其中X.sup.3是氢原子、卤素原子、氰基、氨基、烷基、卤代甲基基团、烷氧基或可能具有取代基团的卤代甲氧基；R是氢原子、苯基、乙酰氧甲基基团、戊酰氧甲基基团、乙氧羰基、胆碱基团、二甲氨基乙基基团、5-茚基团、邻苯二酰基团、5-烷基-2-氧代-1,3-二氧杂环戊-4-基甲基基团、3-乙酰氧基-2-氧代丁基基团、烷基、烷氧甲基或苯基烷基基团，并提供一种用作抗菌药物的杂环化合物。
• Heterocyclic spiro-derivative
  申请人：Daiichi Pharmaceutical Co., Ltd.

  公开号：US06469023B1

  公开（公告）日：2002-10-22

  The present invention provides an antibacterial compound useful as medicines, animal drugs, fisheries drugs or antibacterial preservatives and to an antibacterial agent or preparation which contains the same, more particularly a compound which possesses high safety and excellent activity against a broad range of bacterial species including quinolone-resistant strains. A quinolone derivative of the following formula (I) which has a group derived from the heterocyclic spiro-compound at the 7-positioned R2 and the halogenocyclopropyl group at the N1-position, prefereably a compound of pure isomer, and an antibacterial agent containing the derivative compound.

  本发明提供一种抗菌化合物，可用作药物、动物药品、渔业药品或抗菌防腐剂，以及含有该化合物的抗菌剂或制剂，更具体地说，是一种具有高安全性和对包括喹诺酮耐药菌株在内的广泛细菌种类表现出优异活性的化合物。公式（I）中具有来自杂环螺环化合物的衍生基在7位R2处和卤代环丙基在N1位的喹诺酮衍生物，优选为纯异构体化合物，以及含有衍生物化合物的抗菌剂。
• Aminomethylpyrrolidine derivatives having aromatic substituents
  申请人：DAIICHI PHARMACEUTICAL CO., LTD.

  公开号：US20040209940A1

  公开（公告）日：2004-10-21

  This invention provides a quinolone derivative having potent antibacterial activity against various bacteria including drug-resistant strains which is a compound of the following formula wherein R 1 is an optionally substituted aromatic group, a salt of the same or a hydrate of both. 1 In the formula, R 2 , R 3 : hydrogen atom, an alkyl group; R 4 , R 5 , R 6 : hydrogen atom, hydroxyl group, a halogen atom, carbamoyl group, an alkyl group, an alkoxyl group, an alkylthio group; R 7 , R 8 : hydrogen atom, an alkyl group; R 9 : an alkyl group, an alkenyl group, a halogenoalkyl group, a cyclic alkyl group, an aryl group, a heteroaryl group, an alkoxyl group having from 1 to 6 carbon atoms, an alkylamino group; R 10 :hydrogen atom, an alkylthio group; R 11 : hydrogen atom, amino group, hydroxyl group, thiol group, a halogenomethyl group, an alkyl group, an alkenyl group, an alkynyl group, an alkoxyl group; X 1 : halogen atom, a hydrogen atom; A 1 : nitrogen atom, C-X 2 ; X 2 : hydrogen atom, amino group, a halogen atom, cyano group, an halogenomethyl group, a halogenomethoxyl group, an alkyl group, an alkenyl group, an alkynyl group, an alkoxyl group; A 2 , A 3 :>C═C (-A 1 ═)—N(—R 9 )—, >N—C (-A 1 >)═C(—R 9 )—; R 10 and R 9 or R 9 and X 2 may be integrated to for a ring structure; and Y: hydrogen atom, ester forming group.

  本发明提供了一种喹诺酮衍生物，其具有强效的抗菌活性，可用于治疗包括耐药菌株在内的各种细菌感染。该化合物的结构式如下：其中R1为可选的取代芳基，其盐或水合物。在公式中，R2、R3：氢原子、烷基；R4、R5、R6：氢原子、羟基、卤素原子、氨基甲酰基、烷基、烷氧基、烷硫基；R7、R8：氢原子、烷基；R9：烷基、烯基、卤代烷基、环烷基、芳基、杂环芳基、含有1~6个碳原子的烷氧基、烷基氨基；R10：氢原子、烷硫基；R11：氢原子、氨基、羟基、硫醇基、卤代甲基基、烷基、烯基、炔基、烷氧基；X1：卤素原子、氢原子；A1：氮原子、C-X2；X2：氢原子、氨基、卤素原子、氰基、卤代甲基基、卤代甲氧基基、烷基、烯基、炔基、烷氧基；A2、A3：>C=C(-A1H)-N(-R9)-、>N-C(-A1>)=CH(-R9)-；R10和R9或R9和X2可以结合形成环状结构；Y：氢原子、酯形成基。
• Cycloalkyl-substituted aminomethylpyrrolidine derivatives
  申请人：Daiichi Pharmaceutical Co., Ltd.

  公开号：US06573260B1

  公开（公告）日：2003-06-03

  This invention provides a quinolone derivative which exerts strong antibacterial action upon various bacteria and has high safety, and it relates to a compound having a structure of formula (I), its salts and hydrates thereof: {R1 and R2: hydrogen, alkyl; n: 1 to 4; Q: following structure (Ia): [R3: alkyl, alkenyl, halogenoalkyl, cyclic alkyl, aryl, heteroaryl, alkoxyl, alkylamino; R4: hydrogen, alkylthio; R5: hydrogen, amino, hydroxyl, thiol, halogenomethyl, alkyl, alkenyl, alkynyl, alkoxyl; X1: halogen, hydrogen, A1: nitrogen, structure of formula (II): (X2: hydrogen, amino, halogen, cyano, halogenomethyl, halogenomethyl, alkyl, alkenyl, alkynyl, alkoxyl; R4 and R3 or X2 and R3 may together form a cyclic structure; Y: hydrogen, various ester forming groups]}.

  这项发明提供了一种喹诺酮衍生物，其对各种细菌具有强烈的抗菌作用，并具有高度的安全性，涉及具有结构式（I）、其盐和水合物的化合物：{R1和R2：氢、烷基；n：1至4；Q：以下结构（Ia）：[R3：烷基、烯基、卤代烷基、环烷基、芳基、杂芳基、烷氧基、烷基氨基；R4：氢、烷基硫；R5：氢、氨基、羟基、硫醇、卤代甲基、烷基、烯基、炔基、烷氧基；X1：卤素、氢、A1：氮、结构式（II）：（X2：氢、氨基、卤素、氰基、卤代甲基、卤代甲基、烷基、烯基、炔基、烷氧基；R4和R3或X2和R3可以共同形成环状结构；Y：氢、各种酯形成基）。
• Chinolon- und Naphthyrdioncarbonsäure-Derivate
  申请人：BAYER AG

  公开号：EP0704443A2

  公开（公告）日：1996-04-03

  Die Erfindung betrifft neue Chinolon- und Naphthyridoncarbonsäure-Derivate, die in 7-Stellung durch einen tricyclischen Aminrest substituiert sind, ihre Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel.

  本发明涉及在 7 位被三环胺基取代的新的喹诺酮和萘啶羧酸衍生物、它们的盐、它们的制备工艺以及含有它们的抗菌剂。